Capital Medical University
Beijing, China

Capital University of Medical science , also known as CUMS, CCMU or CMU, is a university in Beijing, China, which was originally called Beijing Second Medical College .Capital Medical University was founded in 1960, with the original name of Beijing Second Medical College . It ranks among the top academic medical institutions in China and is considered as one of the key municipal universities in Beijing. The founding President, Professor Wu Jieping, was a world-renowned urologist, member of both the Chinese Academy of science and the Chinese Academy of Engineering. The current President is Professor Lu Zhaofeng.CMU consists of 10 Schools, 14 affiliated hospitals and 1 teaching institution. The university and the affiliated hospitals have a staff of about 20,000. Among the staff, there are 6 members of the Chinese Academy of science or the Chinese Academy of Engineering, over 1,000 professors, and over 2,000 associate professors. The university has over 9,000 enrolled students. CMU provides a wide range of educational programs for Doctorates, Masters, Bachelors and certificates.The faculty physicians at CMU train annually several thousands of clinical residents and fellows. Also, the faculty members also provide continuous medical education to physicians and other health professionals through seminars, teaching rounds, and tutorials on and off campus. Over the years, the university has graduated a large number of academic leaders and general practitioners for Beijing and the whole country.CMU is a well known academic institution for its strong competence in the scientific research. It hosts many national and municipal key disciplines, laboratories and some exchange stations for post-doctoral research. High-caliber national and municipal research and training centers and institutes are founded here, covering a wide range of fields including General Practitioner Training, Clinical Medicine, Basic Medicine, Neuroscience, Ophthalmology, Geriatrics, Urology, Cardiology, Pain Medicine, Toxicology, Biomedical Engineering, Traditional Chinese Medicine, Reproduction, Health Policy and so on. We have achieved national and international recognitions in many areas such as Neurobiology, Cytobiology, Immunology, Medical Iconography, Neurology, Neurosurgery, Cardiology, Cardio-vascular Surgery, Kidney Transplantation, Respiratory Disease, Digestive Medicine, Oral-Maxillofacial Surgery, Ophthalmology, Otolaryngology and Pediatric Hematology, among others.CMU provides excellent international exchange programs. It has partnerships and agreements with many universities and institutions with more than 20 countries and regions, supporting activities such as faculty and student exchange programs, joint education and joint research projects.CMU is proud to be at the forefront in the medical education, biomedical research and patient care. It is committed to bring the latest knowledge in basic and clinical science for peoples’ care. Wikipedia.

Time filter
Source Type

To clarify the lowering effect of metabolic syndrome (MetS) on serum prostate-specific antigen (PSA) levels in a Chinese screened population.A total of 45 540 ostensibly healthy men aged 55-69 years who underwent routine health check-ups at Beijing Shijitan Hospital between 2008 and 2015 were included in the study. All the men underwent detailed clinical evaluations. PSA mass density was calculated (serum PSA level plasma volume prostate volume) for simultaneously adjusting plasma volume and prostate volume. According to the modified National Cholesterol Education Programme-Adult Treatment Panel (NCEP-ATP) III criteria, patients were dichotomized by the presence of MetS, and differences in PSA density and PSA mass density were compared between groups. Linear regression analysis was used to evaluate the effect of MetS on serum PSA levels.When larger prostate volume in men with MetS was adjusted for, both PSA density and PSA mass density in men with MetS were significantly lower than in men without MetS, and the estimated difference in mean serum PSA level between men with and without MetS was greater than that before adjusting for prostate volume. In the multivariate regression model, the presence of MetS was independently associated with an 11.3% decline in serum PSA levels compared with the absence of MetS. In addition, increasing number of positive MetS components was significantly and linearly associated with decline in serum PSA levels.The actual lowering effect of MetS on serum PSA levels was partly concealed by the enlarged prostate in men with MetS, and the presence of MetS was independently associated with lower serum PSA levels. Urologists need to be aware of the effect of MetS on serum PSA levels and should discuss this subject with their patients.

Loading Capital Medical University collaborators
Loading Capital Medical University collaborators